Add BrightSurf on Google Email

Science News Archive January 2026 - Page 47


Page 47 of 47

Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications

The liver's unique immune tolerance is driven by peptide hormones and bile acids, which activate anti-inflammatory responses and foster a tolerogenic phenotype in resident immune cells. This mechanism may explain the liver's reduced rates of transplant rejection but also poses challenges for treating liver infections.

SourceHigher Education Press·JournalProtein & Cell·TypeExperimental study·DateJan 4, 2026

FPR2 drives intestinal epithelial repair after injury

A recent study reveals that FPR2 activation regulates the proliferation and differentiation of intestinal stem cells (ISCs) and transit-amplifying cells, leading to improved epithelial repair. The study also identified a potential therapeutic target for intestinal damage, highlighting the therapeutic potential of FPR2 agonists.

SourceHigher Education Press·JournalLife Metabolism·TypeExperimental study·DateJan 4, 2026

Artificial empathy in therapy and healthcare: advancements in interpersonal interaction technologies

The review explores how multiplayer games, social robots, and virtual agents can advance artificial empathy in therapy and healthcare by embedding interpersonal interaction. It highlights the need for deeper, more seamless closed-loop interaction and emphasizes the importance of emotion recognition, trust, engagement, and rapport.

SourceBeijing Institute of Technology Press Co., Ltd·JournalCyborg and Bionic Systems·DateJan 4, 2026

Why Some Bacteria Survive Antibiotics and How to Stop Them - New study reveals that bacteria can survive antibiotic treatment through two fundamentally different “shutdown modes”

Researchers identify two archetypes of growth arrest that lead to persistence: regulated and disrupted states. The former provides protection from antibiotics, while the latter is marked by vulnerabilities, particularly impaired cell membrane stability. This distinction has significant implications for developing targeted therapies.

SourceThe Hebrew University of Jerusalem·JournalScience Advances·TypeExperimental study·DateJan 2, 2026

Mathematicians tame cellular “noise” to control life at the single-cell level

Researchers create a novel mathematical framework to control biological noise, enabling precise single-cell control. The 'Noise Robust Perfect Adaptation' technology suppresses stochastic fluctuations while maintaining stable average behavior, with promising applications in cancer therapy and synthetic biology.

SourceInstitute for Basic Science·JournalNature Communications·TypeComputational simulation/modeling·DateJan 2, 2026

Study identifies potential biomarker linked to progression and brain inflammation in multiple sclerosis

A University of Toronto-led study has discovered a potential biomarker linked to multiple sclerosis disease progression that could help identify patients most likely to benefit from new drugs. The findings were validated in both mouse models and humans, suggesting a possible surrogate marker for leptomeningeal inflammation.

SourceUniversity of Toronto·JournalNature Immunology·TypeExperimental study·DateJan 2, 2026

Superradiant spins show teamwork at the quantum scale

Researchers have discovered a new method for generating highly stable and precise microwave signals through self-induced superradiant masing. This phenomenon produces long-lived bursts of microwave emission without external driving, paving the way for technological advances in fields like medicine, navigation, and quantum communication.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalNature Physics·TypeExperimental study·DateJan 2, 2026

Researchers create cells that help the brain keep its cool

Scientists at Lund University have created a new method to directly reprogram glial cells into parvalbumin neurons, which can help regulate brain activity and potentially treat disorders such as schizophrenia and epilepsy. The breakthrough could lead to therapies that replace lost or damaged brain cells in the future.

SourceLund University·JournalScience Advances·TypeExperimental study·DateJan 1, 2026

ASTRO relaunches its foundation with a renewed focus and clearer identity to reflect accelerated progress in radiation oncology

The American Society for Radiation Oncology (ASTRO) has rebranded its research foundation as Speed of Light – The ASTRO Foundation, marking a renewed focus on advancing research and improving patient care. The new initiative aims to strengthen research collaborations and investments to drive progress in radiation oncology.

Dual-salt synergy in interface regulation: in situ atomic force microscopy reveals the stabilization mechanism for lithium metal batteries

Researchers found that combining LiDFOB and LiPF₆ in a dual-salt electrolyte regulates electrode interfaces, forming a double-layer cathode electrolyte interphase and a LiF-rich solid electrolyte interphase. This design lowers interfacial impedance, promotes uniform Li deposition, and enhances durability under cycling.

The global burden of leukemia, 1990–2021: a systematic analysis of prevalence, DALYs, and risk factors from the global burden of disease study

Leukemia prevalence increased by 28.0% globally from 1990 to 2021, alongside a 16.2% decline in disability-adjusted life years (DALYs). Chronic lymphocytic leukemia (CLL) is the most prevalent subtype, while acute myeloid leukemia (AML) contributes the largest proportion of DALYs.

SourceFAR Publishing Limited·JournalMed Research·TypeSystematic review·DateJan 1, 2026

AI-powered R&D acceleration: Insilico Medicine and Hisun Pharma nominate a preclinical candidate just 8 months after forming a strategic collaboration

Insilico Medicine and Hisun Pharma successfully nominated a preclinical candidate using AI-powered R&D in just 8 months after forming a strategic collaboration. The collaboration showcased the acceleration and efficiency gains that AI can bring to drug development, enabling the companies to enhance innovation in early-stage drug discov...

EAST Tokamak experiments exceed plasma density limit, offering new approach to fusion ignition

Researchers at EAST have successfully accessed a theorized 'density-free regime' for fusion plasmas, achieving stable operation at densities beyond conventional limits. This breakthrough provides new insights into overcoming one of the most persistent physical obstacles on the path toward nuclear fusion ignition.

SourceChinese Academy of Sciences Headquarters·JournalScience Advances·TypeExperimental study·DateJan 1, 2026